Palisade Bio, Inc. PALI
1.28 USD +0.04 (+3.66%)
Nov 4, 2026, 9:32 AM EST
1.26 Day range 1.28
1.08 52-week range 2.86
- YTD
- -45.74%
- 1 year
- -30.71%
Analyst view
Price target (mean) 30.33 +2279.1% upside
Now 1.28
- Target (low)
- 8.00
- Target (mean)
- 30.33
- Target (high)
- 45.00
Ratings (0m) 3 3 buy · 0 hold · 0 sell
- Strong buy1
- Buy2
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 3
- 1 month ago 3
- 2 months ago 2
- 3 months ago 2
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -2.58 | -2.76 – -2.39 | -3.75 | +31.3% | 0 | 0.0% | 2 |
| Current year | -11.97 | -12.20 – -11.74 | -27.00 | +55.7% | 0 | -100.0% | 2 |
| Next year | -3.81 | -5.45 – -1.86 | -11.97 | +68.2% | 0 | 0.0% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 20, 2024 | Brookline Capital | Initiated | — | Buy |
| Nov 13, 2024 | Maxim Group | Maintained | Buy | Buy |
| May 1, 2024 | Maxim Group | Reiterated | Buy | Buy |
| Apr 16, 2024 | Maxim Group | Maintained | Buy | Buy |
| Nov 17, 2023 | Maxim Group | Upgrade | Hold | Buy |
| May 16, 2023 | Ladenburg Thalmann | Maintained | Buy | Buy |
| Mar 30, 2023 | Maxim Group | Upgrade | Hold | Buy |